Young Cancer Patient's Tenacity Inspires Family, Friends and Strangers

Jimmy E. is a remarkable man. Inspired by the doctors who helped him overcome a rare form of childhood cancer, he forged a career as a skilled surgical nurse in southern California, driven by an urge to serve others. But more than 30 years after beating cancer, Jimmy developed a persistent fever, pneumonia and fluid around his lungs. This time, the diagnosis was a more insidious disease — malignant pleural mesothelioma. Jimmy, who recently turned 38, is far too young for a disease that typically strikes the elderly. As he struggles to rise above each setback, now it's Jimmy inspiring others around him, including family, friends and strangers he never met, and never will. In the last three months, 122 people have contributed more than $12,200 to his “Please Help Jimmy!” campaign on GoFundMe.com. The goal is to reach $25,000 to cover medical costs. "I never knew, never guessed, that there were so many people who cared and would reach out to help," said Linda, his mother and primary caregiver. "There are people all over the world who are praying for him now. It's been amazing to see how people have responded. In a way, it's been inspiring to see." First Encounter with Cancer Cancer first struck Jimmy at age six. Doctors told his parents he had fibrosarcoma, a rare, soft-tissue cancer that originated around his jaw. They said there was a 70 percent chance he would die soon. Multiples surgeries, high-dose radiation and several rounds of...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Tags: Stories from Survivors Source Type: news

Related Links:

Publication date: 10–16 November 2018Source: The Lancet, Volume 392, Issue 10159Author(s): Gregory A Roth, Degu Abate, Kalkidan Hassen Abate, Solomon M Abay, Cristiana Abbafati, Nooshin Abbasi, Hedayat Abbastabar, Foad Abd-Allah, Jemal Abdela, Ahmed Abdelalim, Ibrahim Abdollahpour, Rizwan Suliankatchi Abdulkader, Haftom Temesgen Abebe, Molla Abebe, Zegeye Abebe, Ayenew Negesse Abejie, Semaw F Abera, Olifan Zewdie Abil, Haftom Niguse Abraha, Aklilu Roba AbrhamSummaryBackgroundGlobal development goals increasingly rely on country-specific estimates for benchmarking a nation's progress. To meet this need, the Global Bur...
Source: The Lancet - Category: General Medicine Source Type: research
ConclusionIGM is an uncommon benign disease which is hardly distinguished from malignancy. There is not a significant difference among treatment modalities in term of time-to-healing and recurrence of disease. The result shows that surgery is outperformed by the shortest healing time. However, the surgical treatment must be chosen with careful due to high rate of wound complications. Multimodality treatment is recommended as the proper treatments for IGM patient.
Source: Annals of Medicine and Surgery - Category: General Medicine Source Type: research
Publication date: Available online 10 November 2018Source: Journal of Hospital InfectionAuthor(s): Sebastian M. Heimann, Maria J.G.T. Vehreschild, Oliver A. Cornely, Werner J. Heinz, Beate Grüner, Gerda Silling, Johanna Kessel, Danila Seidel, Jörg Janne VehreschildAbstractBackgroundInvasive mucormycosis (IM) is a rare invasive fungal infection with high mortality rates. However, data concerning the clinical and economic burden of IM are scarce.AimTo evaluate the direct treatment costs and additional expenditures of patients with IM.MethodsWe performed a retrospective cost-of-illness analysis of cases with IM extr...
Source: Journal of Hospital Infection - Category: Infectious Diseases Source Type: research
ConclusionsThis ‘real-world’ data will provide valuable information to better inform etiological hypotheses and plan future health-care services.
Source: Cancer Epidemiology - Category: Cancer & Oncology Source Type: research
Discussion: There were no differences in survival between the group using transdermal fentanyl and the group using buprenorphine in the elderly hospice population. Although adjuvant NSAIDs could be useful in the treatment of pain in terminal cancer, they do not affect survival or reduce the opioid doses, while a 1:80 equianalgesic ratio of buprenorphine might be the most appropriate in this population. PMID: 30410797 [PubMed]
Source: Pain Research and Treatment - Category: Anesthesiology Tags: Pain Res Treat Source Type: research
Authors: Cegla P, Wierzchoslawska E, Marszalek A, Gwozdz S, Cholewinski W Abstract Hodgkin's lymphoma and lung adenocarcinoma as second primary cancers in prostate cancer (PC) patients although are rare should be considered as important for the future of the PC patients. PMID: 30411733 [PubMed - as supplied by publisher]
Source: Hellenic Journal of Nuclear Medicine - Category: Nuclear Medicine Tags: Hell J Nucl Med Source Type: research
Authors: Kratzik C, Dorudi S, Schatzl M, Sinzinger H Abstract OBJECTIVE: The introduction of the prostate specific membrane antigen (PSMA) offers the possibility to discover prostate cancer recurrences being frequently so small that they cannot be detected by conventional imaging modalities, such as magnetic resonance or computed tomography. SUBJECTS AND METHODS: A 78 years old patient after radical prostatectomy and lymphadenectomy suffered from recurrence of the disease and galium-68-PSMA (68Ga-PSMA) showed a single hot spot. Therefore, the first time in this indication in Austria radioguided surgery was perf...
Source: Hellenic Journal of Nuclear Medicine - Category: Nuclear Medicine Tags: Hell J Nucl Med Source Type: research
CONCLUSION: The semi-quantitative analysis of 18F-FDG PET/CT has an important role in MPM therapy response assessment and has a predictive role in distinguishing responders and non-responders. PMID: 30411729 [PubMed - as supplied by publisher]
Source: Hellenic Journal of Nuclear Medicine - Category: Nuclear Medicine Tags: Hell J Nucl Med Source Type: research
This study assessed a national healthcare intervention launched in Sweden in 2015 to reduce the time between macroscopic haematuria, diagnosis and treatment of urinary tract cancer. METHODS: The outcome of the first 11 months was evaluated in 1697 individuals referred to a standardized care pathway for urinary tract cancer compared with 174 patients with conventionally diagnosed urothelial carcinoma. RESULTS: Among the referred individuals, 317 (19%) were diagnosed with cancer, 1034 (61%) had a benign diagnosis and 345 (20%) had a negative evaluation. Bladder cancer was the most common malignant diagnosis [262/317 ...
Source: Scandinavian Journal of Urology - Category: Urology & Nephrology Tags: Scand J Urol Source Type: research
Abstract As advances in medical technology arise and the availability of cancer treatment increases, an increased number of patients are receiving cancer treatment. Radiation therapy has evolved to become one of the cornerstones of treatment for various types of cancers. One of the long-term consequences of radiation therapy is radiation-induced coronary artery disease (RICAD). Although the pathophysiology of RICAD may be slightly different and more acute onset than the commonly seen "generic" coronary artery disease, it is common practice to treat RICAD in the same method as nonradiation-induced CAD. Th...
Source: Cardiology Research and Practice - Category: Cardiology Authors: Tags: Cardiol Res Pract Source Type: research
More News: Asbestosis | Cancer | Cancer & Oncology | Chemotherapy | Childhood Cancer | Children | Emergency Medicine | Environmental Health | Fibrosarcoma | Health | Hospitals | Lung Transplant | Mesothelioma | Nurses | Nursing | Pneumonia | Transplants | Websites